The Chairman of the Pharmaceutical Authority discusses with representatives of a global company to localize its products in Egypt
Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Pharmaceutical Authority, held a meeting with representatives of a global company, to discuss the latest developments in the file of resettlement of some of the company’s products in Egypt.
came & nbsp; National Pharmacy.
D. Ali Al -Ghamrawi, the importance of working to implement a plan to localize the company’s products in the Egyptian drug market, ensuring the start of local production at the earliest time, explaining the authority’s keenness to enhance local industries and resettle the drug through immediate dealing with any challenges facing the implementation of localization plans. Medical preparations in Egypt. Remove the obstacles that may hinder the implementation of plans and initiatives, stressing the durability of the relationship that brings the Egyptian Medicine Authority to the company, and the active role that these partnerships play in achieving sustainable development and enhancing national capabilities in the field of pharmaceutical industries.
participated in the meeting by the Egyptian Pharmaceutical Authority, d. Amani Jawdat, Associate Chairman and Supervisor of the Central Administration of the Office of the Chairman of the Authority, and Dr. Asma Fouad, Head of the Central Administration for Biological and Innovative Products and Clinical Studies, and Dr. Osama Hatem, Associate Chairman of the Authority for Policy and International Cooperation, and the supervisor of the Central Administration for Pharmaceutical Policy and Markets, and by the World Company, d. Sami Karam, Vice President of the Company for the Rising Markets, and Dr. Asem Suffer, Vice President of the Middle East, Turkey, Africa and the Association of Independent Countries, and Dr. Barbaros Durgon, Market Support Director for the Middle East, Turkey, Africa and the Association of Independent Countries, and Dr. Mohamed Kandil, Regional Director of Egypt, Saudi Arabia and Africa, and Dr. Hani Hansear, Director of Governmental Affairs for the Middle East, and Dr. Amr Yahya, director of the company in Egypt, and Dr. Naji Helmy, Director of Pharmaceutical Policy and Government Relations at the company, and Dr. Basant Ibrahim, Director of Organizational Affairs at the company.
- For more: Elrisala website and for social networking, you can follow us on Facebook
- Source of information and images “rosaelyoussef”“
